{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:25:21Z","timestamp":1792668321868,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010470","name":"Kommission zur F\u00c3\u00b6rderung der wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["ZFP308390"],"award-info":[{"award-number":["ZFP308390"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejpb.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T11:09:15Z","timestamp":1586603355000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Hydrophobic ion pairing (HIP) of (poly)peptide drugs: Benefits and drawbacks of different preparation methods"],"prefix":"10.1016","volume":"151","author":[{"given":"Richard","family":"Wibel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian David","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Zaichik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17\u201318","key":"10.1016\/j.ejpb.2020.04.004_b0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discovery Today"},{"issue":"10","key":"10.1016\/j.ejpb.2020.04.004_b0010","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: Historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejpb.2020.04.004_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","article-title":"SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs","volume":"142","author":"Mahmood","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2020.04.004_b0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","article-title":"Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione","volume":"523","author":"Het\u00e9nyi","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2020.04.004_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2018.01.018","article-title":"Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating","volume":"538","author":"Griesser","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"14","key":"10.1016\/j.ejpb.2020.04.004_b0030","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.04.004_b0035","doi-asserted-by":"crossref","first-page":"255101","DOI":"10.1088\/0957-4484\/26\/25\/255102","article-title":"Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies","volume":"26","author":"Battaglia","year":"2015","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.ejpb.2020.04.004_b0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1166\/jbn.2012.1371","article-title":"The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex","volume":"8","author":"Zhang","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.ejpb.2020.04.004_b0045","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3109\/10717544.2016.1143056","article-title":"Development and in vitro evaluation of an oral SEDDS for desmopressin","volume":"23","author":"Zupancic","year":"2016","journal-title":"Drug Delivery"},{"issue":"1","key":"10.1016\/j.ejpb.2020.04.004_b0050","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1208\/aapsj070104","article-title":"Carrier-based strategies for targeting protein and peptide drugs to the lungs","volume":"7","author":"Cryan","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.04.004_b0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2020.04.004_b0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2006.11.035","article-title":"Characterization of physiochemical and biological properties of an insulin\/lauryl sulfate complex formed by hydrophobic ion pairing","volume":"336","author":"Dai","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2017.02.019","article-title":"Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems","volume":"520","author":"Griesser","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2015.04.013","article-title":"Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems","volume":"97","author":"Karaminidou","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2020.04.004_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1023\/A:1011998014474","article-title":"Hydrophobic ion pairing; altering the solubility properties of biomolecules","volume":"15","author":"Meyer","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.04.004_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.05.047","article-title":"In vivo evaluation of an oral self-microemulsifying drug delivery sysstem (SMEDDS) for leuprorelin","volume":"472","author":"Hintzen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2019.01.039","article-title":"Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis","volume":"559","author":"Chamieh","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2019.03.001","article-title":"Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release","volume":"561","author":"Nazir","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0095","first-page":"3049","article-title":"Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin","volume":"6","author":"Sun","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2020.04.004_b0100","doi-asserted-by":"crossref","first-page":"458128","DOI":"10.1155\/2011\/458128","article-title":"Encapsulation of protein-polysaccharide HIP complex in polymeric nanoparticles","volume":"2011","author":"Gaudana","year":"2011","journal-title":"J. Drug Delivery"},{"issue":"8","key":"10.1016\/j.ejpb.2020.04.004_b0105","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method for total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"2","key":"10.1016\/j.ejpb.2020.04.004_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0005-2736(99)00209-6","article-title":"A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability","volume":"1463","author":"Stuart","year":"2000","journal-title":"BBA"},{"key":"10.1016\/j.ejpb.2020.04.004_b0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.xphs.2017.05.019","article-title":"Transformation of BCS class I and III drugs into ionic liquids and lipophilic salts for enhanced developability using lipid formulations","volume":"107","author":"Williams","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.004_b0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2019.05.008","article-title":"Unlocking the full potential of lipid-based formulations using lipophilic salt\/ionic liquid forms","volume":"142","author":"Williams","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.04.004_b0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2018.11.010","article-title":"Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration","volume":"554","author":"Zaichik","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.004_b0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(00)00457-9","article-title":"Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegrable polymeric nanospheres","volume":"203","author":"Choi","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2020.04.004_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/jps.20100","article-title":"Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers","volume":"93","author":"Wong","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.004_b0140","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/j100454a016","article-title":"Micelle formation of ionic surfactants in polar nonaqueous solvents","volume":"17","author":"Singh","year":"1980","journal-title":"J. Phys. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2020.04.004_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11743-015-1755-x","article-title":"The effect of methanol on the micellar properties of dodecyltrimethylammonium bromide (DTAB) in aqueous medium at different temperatures","volume":"19","author":"Shah","year":"2016","journal-title":"J. Surf. Deterg."},{"issue":"11","key":"10.1016\/j.ejpb.2020.04.004_b0150","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/C9NA00308H","article-title":"Hydrophobic ion pairing: encapsulating small molecules, peptides and proteins into nanocarriers","volume":"1","author":"Ristroph","year":"2019","journal-title":"Nanoscale Adv."},{"issue":"4","key":"10.1016\/j.ejpb.2020.04.004_b0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/ijms18040708","article-title":"\u201cBligh and Dyer\u201d and Folch methods for solid-liquid-liquid extraction of lipids from microorganisms. Comprehension of solvatation mechanisms and towards substitution with alternative solvents","volume":"18","author":"Breil","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"52","key":"10.1016\/j.ejpb.2020.04.004_b0160","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.1021\/bi020525z","article-title":"Surface denaturation and amyloid fibril formation of insulin at model lipid\u2013water interfaces","volume":"41","author":"Sharp","year":"2002","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.ejpb.2020.04.004_b0165","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1023\/A:1013334916162","article-title":"In situ study of insulin aggregation induced by water-organic solvent interface","volume":"18","author":"Kwon","year":"2001","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2020.04.004_b0170","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jps.10116","article-title":"Hydrophobic ion pairing of isoniazid using a prodrug approach","volume":"91","author":"Zhou","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2020.04.004_b0175","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1023\/A:1018977225919","article-title":"Ion-pair partition of quaternary ammonium drugs: the influence of counter ions of different lipophilicity, size, and flexibility","volume":"16","author":"Tak\u00e1cs-Nov\u00e1k","year":"1999","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:37:02Z","timestamp":1760546222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120300977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":35,"alternative-id":["S0939641120300977"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrophobic ion pairing (HIP) of (poly)peptide drugs: Benefits and drawbacks of different preparation methods","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}